Axsome says U.S. FDA asks for no extra data for depression drug, shares surge | Reuters

Retrieved on: 2021-08-23 10:16:07

Tags for this article:

Psychoactive drugs

Drugs

Antidepressants

Psychology

Selective serotonin reuptake inhibitors

Psychiatric diagnosis

Major depressive disorder

Bupropion/dextromethorphan

Fluoxetine

Sertraline

Food and Drug Administration

Depression

Axsome Therapeutics Inc

Click the tags to see associated articles and topics

Axsome says U.S. FDA asks for no extra data for depression drug, shares surge | Reuters. View article details on hiswai:

Excerpt

Analysts had expected the FDA to decline Axsome's application, with Truist Securities analyst Joon Lee saying the lack of a "complete response letter" from ...

Article found on: www.reuters.com

View Original Article